Fund Mojo help you discover the best fund managers, funds, and related information

Fund Intelligence | Best Managers | PRHSX Insights | PRHSX Score | PRHSX Performance | PRHSX News | PRHSX Allocation | PRHSX Holdings Change

T. Rowe Price Health Sciences (PRHSX) Fund Ranking and Research

Ranking, Research and Recommendation of T. Rowe Price Health Sciences (PRHSX) Fund

    Last Trade: $73.33 on 9/22/2017, Change: -0.04 (-0.05%)

 

Graph of T. Rowe Price Health Sciences Fund (PRHSX) ManagerFund Manager - Ziad Bakri

Fund Manager Information

Fund Manager Tenure: 1.5 years
Fund Family: T. Rowe Price
Fund Category: Health
Fund Performance: May 30, 2016
Fundmojo Fund Grade: N/A (Score: *Manager is New*)     (What does this score mean?)

 

Graph of T. Rowe Price Health Sciences Fund (PRHSX) ProfileT. Rowe Price Health Sciences Fund (PRHSX) Profile

Fund Profile and Description

T. Rowe Price Health Sciences Fund seeks long-term capital appreciation. T. Rowe Price Health Sciences Fund normally invests at least 80% of assets in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences. While it can invest in companies of any size, the fund invests the majority of assets in large- and mid-capitalization companies.

 

T. Rowe Price Health Sciences (PRHSX) Fund Strength What we like about T. Rowe Price Health Sciences (PRHSX) Fund

Data for T. Rowe Price Health Sciences Fund (PRHSX) as of May 30, 2016

  • T. Rowe Price Health Sciences Fund (PRHSX) has good short-term performance (1-year return -12.89% vs -12.93% Health category median performance)
  • T. Rowe Price Health Sciences Fund (PRHSX) has good mid-term performance (3-year return 19.50% vs 15.21% Health category median performance)
  • T. Rowe Price Health Sciences Fund (PRHSX) has good Long-term performance (5-year return 20.35% vs 16.08% Health category median performance)
  • T. Rowe Price Health Sciences Fund (PRHSX) ratio of up-years vs down years is greater than 2
  • T. Rowe Price Health Sciences Fund (PRHSX) has a Morningstar rating of 4 and above
  • T. Rowe Price Health Sciences Fund (PRHSX) has an annual stock turnover rate of 31.00% vs Health average of 43.99%. It is good that T. Rowe Price Health Sciences management does not trade extensively for its return.
  • T. Rowe Price Health Sciences Fund (PRHSX) is less volatile than its peers as it has a 3-year Standard Deviation of 17.17, lower than category average of 17.59
  • T. Rowe Price Health Sciences Fund (PRHSX) has a lower expense ratio than its Health average: 0.76% vs 1.32%
  • T. Rowe Price Health Sciences Fund (PRHSX) is a true no-load fund as it has no load and no 12b1 promotion, distributions, marketing expenses

T. Rowe Price Health Sciences Fund (PRHSX) Weakness What we are cautious about T. Rowe Price Health Sciences (PRHSX) Fund

Data for T. Rowe Price Health Sciences Fund (PRHSX) as of May 30, 2016

  • T. Rowe Price Health Sciences Fund (PRHSX) management has been with T. Rowe Price Health Sciences Fund for only 1.5 years, it is hard to judge manager's ability based on this fund's operation record
  • As a Health focused fund, T. Rowe Price Health Sciences Fund (PRHSX) is less diversified and has inherited sector risks associated with the fund
See T. Rowe Price Health Sciences Fund (PRHSX) performance details as of May 30, 2016

 

What do you think?

 

Compare T. Rowe Price Health Sciences Fund (PRHSX)Compare with other top Health category mutual funds

Aadditional top Health mutual funds for your consideration

FundYear to Date1 Year3 year5 year
T. Rowe Price Health Sciences-7.58-12.8919.5020.35
Fidelity Advisor Health Care A (FACDX)-5.84-13.4918.7717.80Compare
Hartford Healthcare A (HGHAX)-6.82-7.8017.3816.39Compare
Janus Global Life Sciences T (JAGLX)-7.78-15.8319.3919.37Compare

See top fund managers for Health Category Funds

 

Compare T. Rowe Price Health Sciences Fund (PRHSX)Compare with Health category ETFs

Some Health ETFs for your consideration

ETFYear to DateOne YearThree Year
First Trust NYSE Arca Biotech ETF (FBT)000
SPDR S&P Health Care Equipment ETF (XHE)000
SPDR S&P Biotech ETF (XBI)000
PowerShares S&P SmallCap Health Care ETF (PSCH)000
PowerShares Dynamic Pharmaceuticals ETF (PJP)000

 

Graph of T. Rowe Price Health Sciences Fund (PRHSX) Net Asset TrackingT. Rowe Price Health Sciences (PRHSX) Fund Net Asset

Track net asset change of T. Rowe Price Health Sciences fund (PRHSX)

DateNet Asset
05/2016$11.80B
03/2016$11.78B
02/2016$12.00B
More historic net asset information on T. Rowe Price Health Sciences Fund (PRHSX)

  

Graph of T. Rowe Price Health Sciences Fund (PRHSX) Portfolio TrackingT. Rowe Price Health Sciences (PRHSX) Fund Portfolio Allocation

Track portfolio allocation change of T. Rowe Price Health Sciences fund (PRHSX)

DateCashStockBondOther
03/20161.11%97.71%0%1.07%
12/20152.55%95.96%0%1.36%
09/20154.2%94.12%0%1.54%
Click here to see more historic asset allocation information on T. Rowe Price Health Sciences Fund (PRHSX)

 

graph of T. Rowe Price Health Sciences Fund (PRHSX) Top 10 Position TrackingTop 10 Holdings in T. Rowe Price Health Sciences (PRHSX) Fund

Discover what T. Rowe Price Health Sciences Fund (PRHSX) manager is buying

Mar 30, 2016
Allergan plc Ordinary Shares [6.17%]
Humana Inc. Common Stock [4.59%]
UnitedHealth Group Incorporated [4.56%]
Alexion Pharmaceuticals, Inc. [4.03%]
Aetna Inc. Common Stock [3.95%]
Thermo Fisher Scientific Inc Co [3.27%]
Cigna Corporation Common Stock [3.23%]
Bristol-Myers Squibb Company Co [2.95%]
Becton, Dickinson and Company C [2.83%]
Gilead Sciences, Inc. [2.73%]

Dec 30, 2015
Allergan plc Ordinary Shares [5.96%]
Alexion Pharmaceuticals, Inc. [4.57%]
UnitedHealth Group Incorporated [3.69%]
Humana Inc. Common Stock [3.41%]
Aetna Inc. Common Stock [3.15%]
Cigna Corporation Common Stock [2.85%]
Gilead Sciences, Inc. [2.72%]
Thermo Fisher Scientific Inc Co [2.72%]
Incyte Corporation [2.55%]
Regeneron Pharmaceuticals, Inc. [2.51%]

Sep 29, 2015
Allergan PLC [4.97%]
Alexion Pharmaceuticals, Inc. [3.93%]
UnitedHealth Group Incorporated [3.81%]
Humana Inc. Common Stock [3.44%]
Aetna Inc. Common Stock [3.34%]
VALEANT PHARMACEUTICALS INTL IN [3.32%]
Gilead Sciences, Inc. [3.04%]
Cigna Corporation Common Stock [2.91%]
Incyte Corporation [2.71%]
McKesson Corporation Common Sto [2.3%]
Click here for Stock Holding Change Map in T. Rowe Price Health Sciences Fund (PRHSX)

  

Latest News on T. Rowe Price Health Sciences (PRHSX) Fund

See what is happening with T. Rowe Price Health Sciences Fund (PRHSX)

 

T. Rowe Price Health Sciences Fund (PRHSX) Related ResourcesSee more information on T. Rowe Price Health Sciences (PRHSX) Fund

Popular pages on T. Rowe Price Health Sciences (PRHSX) Fund

  

Fund Mojo Newsletter

Fund Mojo on Facebook Follow FundMojo on Twitter Fund Update